Generating AI analysis...
AI Earnings Analysis
| Metric | Current | Previous | YoY Change |
|---|---|---|---|
Revenue | $1.71M | $18.07M | -90.54% |
Operating Income | $-204.56M | $-145.22M | -40.86% |
Net Income | $-191.7M | $-134.34M | -42.69% |
EPS (Basic) | $-2.33 | $-1.81 | -28.73% |
EPS (Diluted) | $-2.33 | $-1.81 | -28.73% |
R&D Expense | $150.64M | $108.09M | +39.36% |
| Metric | Current | Previous | YoY Change |
|---|---|---|---|
Total Assets | $327.57M | $504.65M | -35.09% |
Current Assets | $271.14M | $358.6M | -24.39% |
Total Liabilities | $151.93M | $144.19M | +5.37% |
Current Liabilities | $72.35M | $58.6M | +23.46% |
Stockholders' Equity | $175.63M | $360.46M | -51.28% |
Cash & Equivalents | $95.83M | $82.54M | +16.11% |
| Metric | Current | Previous | YoY Change |
|---|---|---|---|
Operating Cash Flow | $-159.52M | $-109.94M | -45.10% |
Investing Cash Flow | $131.19M | $-66.57M | +297.06% |
Financing Cash Flow | $514,000 | $117.53M | -99.56% |
| Metric | Current | Previous | YoY Change |
|---|---|---|---|
Operating Margin | -11962.5% | -803.5% | -11159.05% |
Net Margin | -11210.4% | — | — |
ROE | -109.1% | — | — |
ROA | -58.5% | — | — |
Current Ratio | $3.747 | — | — |
Debt to Equity | $0.865 | — | — |
Other companies in Biotechnology